Skip to main content
Article
Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease
Psychiatry Publications and Presentations
  • Dominic J. Gessler, University of Massachusetts Medical School
  • Danning Li, University of Massachusetts Medical School
  • Hongxia Xu, University of Massachusetts Medical School
  • Qin Su, University of Massachusetts Medical School
  • Julio Sanmiguel, University of Massachusetts Medical School
  • Serafettin Tuncer, Heinrich Heine University
  • Constance M. Moore, University of Massachusetts Medical School
  • Jean A. King, University of Massachusetts Medical School
  • Reuben Matalon, University of Texas Medical Branch
  • Guangping Gao, University of Massachusetts Medical School
UMMS Affiliation
Department of Microbiology and Physiological Systems; Horae Gene Therapy Center; Center for Comparative Neuroimaging, Department of Psychiatry
Date
2-9-2017
Document Type
Article
Abstract
Canavan disease (CD) is a debilitating and lethal leukodystrophy caused by mutations in the aspartoacylase (ASPA) gene and the resulting defect in N-acetylaspartate (NAA) metabolism in the CNS and peripheral tissues. Recombinant adeno-associated virus (rAAV) has the ability to cross the blood-brain barrier and widely transduce the CNS. We developed a rAAV-based and optimized gene replacement therapy, which achieves early, complete, and sustained rescue of the lethal disease phenotype in CD mice. Our treatment results in a super-mouse phenotype, increasing motor performance of treated CD mice beyond that of WT control mice. We demonstrate that this rescue is oligodendrocyte independent, and that gene correction in astrocytes is sufficient, suggesting that the establishment of an astrocyte-based alternative metabolic sink for NAA is a key mechanism for efficacious disease rescue and the super-mouse phenotype. Importantly, the use of clinically translatable high-field imaging tools enables the noninvasive monitoring and prediction of therapeutic outcomes for CD and might enable further investigation of NAA-related cognitive function.
Rights and Permissions
Citation: JCI Insight. 2017 Feb 9;2(3):e90807. doi: 10.1172/jci.insight.90807. Link to article on publisher's site
Related Resources
Link to Article in PubMed
PubMed ID
28194442
Citation Information
Dominic J. Gessler, Danning Li, Hongxia Xu, Qin Su, et al.. "Redirecting N-acetylaspartate metabolism in the central nervous system normalizes myelination and rescues Canavan disease" Vol. 2 Iss. 3 (2017) ISSN: 2379-3708 (Linking)
Available at: http://works.bepress.com/jean_king/73/